TGTX
TG Therapeutics Inc
Price:  
37.09 
USD
Volume:  
957,653
United States | Biotechnology

TGTX Gross Margin

As of 2025-07-12, the Gross Margin of TG Therapeutics Inc (TGTX) is 88.3%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

TGTX Gross Margin - Historical Value
DateValue
2024-12-31 88.3%
2023-12-31 94%
2022-12-31 90.5%
2021-12-31 88.2%
2020-12-31 -
2019-12-31 -
2018-12-31 -
2017-12-31 -
2016-12-31 -
2015-12-31 -
TGTX Gross Margin - Peers Comparison